ÅÁÂÞÎ÷Í¡ÁªºÏÖظ´¾Â´Å´Ì¼¤ÖÎÁÆ
Å®ÐÔ¸üÄêÆÚÒÖÓôÖ¢µÄ¶ÔÕÕÑо¿
½ðÒãÇí
【ժҪ】Ä¿µÄ̽ÌÖÅÁÂÞÎ÷Í¡ÁªºÏÖظ´¾Â´Å´Ì¼¤(rTMS)¶ÔÅ®ÐÔ¸üÄêÆÚ ÒÖÓôÖ¢µÄÁÆЧ。·½·¨²ÉÓÃËæ»úÊý×Ö±í
·¨½«·ûºÏ《¹ú¼Ê¼²²¡·ÖÀà(µÚ10°æ)》(ICD - 10)ÒÖÓôÖ¢Õï¶Ï±ê×¼µÄ72Àý¸üÄêÆÚÅ®ÐÔ»¼Õß·ÖΪÑо¿×éºÍ¶ÔÕÕ×é¸÷36
Àý£¬Ñо¿×é²ÉÓÃÅÁÂÞÎ÷Í¡ÁªºÏrTMSÖÎÁÆ£¬¶ÔÕÕ×éµ¥ÓÃÅÁÂÞÎ÷Í¡ÖÎÁÆ£¬²ÉÓúºÃܶû¶ÙÒÖÓôÁ¿±í17Ïî°æ(HAMD - 17)、ºº
Ãܶû¶Ù½¹ÂÇÁ¿±í(HAMA)、Á÷µ÷ÓÃÒÖÓô×ÔÆÀÁ¿±í(CES - D)ÓÚÖÎÁÆÇ°¼°ÖÎÁƺóµÚ2、4、6、8ÖÜÆÀ¶¨ÁÆЧ£¬²ÉÓø±·´Ó¦Á¿
±í(TESS)ÆÀ¶¨²»Á¼·´Ó¦。½á¹ûÑо¿×éÓë¶ÔÕÕ×éÓÐЧÂÊ·Ö±ðΪ94. 4%ºÍ75. 0%£¬²îÒìÓÐͳ¼ÆѧÒâÒå(P< 0. 01)。´Ó
ÖÎÁƵÚ1ÖÜÄ©¿ªÊ¼£¬Ñо¿×éHAMD - 17、HAMA¼°CES - DÆÀ·ÖÓëÖÎÁÆÇ°±È½Ï£¬²îÒì¾ùÓÐͳ¼ÆѧÒâÒå(P¾ù< 0. 01)
£¬´Ó
ÖÎÁƵÚ2ÖÜÄ©¿ªÊ¼£¬¶ÔÕÕ×éHAMD - 17、HAMA¼°CES - DÆÀ
·ÖÓëÖÎÁÆÇ°±È½Ï£¬²îÒì¾ùÓÐͳ¼ÆѧÒâÒå(P¾ù< 0. 01)。
ÖÎÁƺóÁ½×éͬÆڱȽϲîÒìÓÐͳ¼ÆѧÒâÒå(P< 0. 01)。ÖÎÁƽáÊøʱÁ½×éTESSÆÀ·Ö²îÒìÎÞͳ¼ÆѧÒâÒå(P> 0. 05)。½á
ÂÛÅÁÂÞÎ÷Í¡ÁªºÏrTMS¶ÔÅ®ÐÔ¸üÄêÆÚÒÖÓôÖ¢ÁÆЧÓÅÓÚµ¥ÓÃÅÁÂÞÎ÷Í¡£¬ÆðЧ½Ï¿ì。
【¹Ø¼ü´Ê】Öظ´¾Â´Å´Ì¼¤;Å®ÐÔ¸üÄêÆÚÒÖÓôÖ¢;ÅÁÂÞÎ÷Í¡
ÖÐͼ·ÖÀàºÅ:R749. 4 ÎÄÏ×±êʶÂë:A doi :10. 11886 /j. issn. 1007-3256. 2015. 06. 009
Controlled study on paroxetine combined with repetitive transcranial magnetic
stimulation in the treatment of female climacteric depression
JIN Yi-qiong
The Third Hospital of Tianshui£¬Tianshui741000£¬China
【Abstract】ObjectiveTo investigate the clinical efficacy of paroxetine combined repetitive transcranial mag
檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾檾
netic stimulation
¸ÉÔ¤ÄÜÃ÷ÏÔ¸ÄÉÆ°©Ö¢»¼Õß½¹ÂÇ、ÒÖÓôÇéÐ÷£¬Ìá¸ß»¼Õß
Éú´æÖÊÁ¿。Õë¶ÔÖ±³¦°©»¼ÕßʵʩÕë¶ÔÐÔµÄÐÄÀí¸ÉÔ¤
ÊǽñºóµÄÑо¿·½Ïò。±¾Ñо¿µÄ¾ÖÏÞÐÔÔÚÓÚÑù±¾Á¿½Ï
С£¬Ä³Ð©ÄêÁä¶Î·Ö²¼²»¾ùºâ£¬Î´¿¼ÂǼ²²¡µÄ·ÖÆÚ。
²Î ¿¼ ÎÄ Ï×
£Û1£ÝSarafino EP.½¡ ¿µÐÄÀíѧ£ÛM£Ý. 4°æ.ºúÅå³ÏµÈÒë.±±¾©.ÖйúÇá
¹¤Òµ³ö°æÉ磬2006:445 - 446.
£Û2£ÝOlschewski M£¬Schulgen G£¬Schumacher M£¬et al. Quality of life assess-
ment in clinical cancer research£ÛJ£Ý. Br J Cancer£¬1994£¬70(1)
:1 -5.
£Û3£ÝFayers P£¬Aaronson N£¬Bjordal K£¬et al
2015 帕罗西汀联合重复经颅磁刺激治疗女性更年期抑郁症的对照研究